DR. MED. CHRISTINA JOOSTEN-STAAR
0845.671.635 · rovalta.com · 27/09/2026
NORMAL SITUATION
DR. MED. CHRISTINA JOOSTEN-STAAR
Company — Normal situation.
Financial year 2022 · Closed on 31/12/2022
Net result6,4 k €-78,1 %over 1 year
Gross margin45,1 k €+20,7 %over 1 year
Equity388,7 k €-1,6 %over 1 year
Overview
Identity
Source · BCE/KBODR. MED. CHRISTINA JOOSTEN-STAAR is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0845.671.635
- Legal form
- Private limited company
- Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2022
Joint committees (1)
- 330
Signals
ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 11 filingsTrend over 10 financial years
| 2022 | 2021 | 2020 | 2019 | 2018 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 45,1 k € | +20.7% | 37,3 k € | -36.0% | 58,3 k € | -54.4% | 128 k € | +13.1% | 113,3 k € |
| EBITDA | 44,5 k € | +21.1% | 36,7 k € | -36.4% | 57,7 k € | -54.7% | 127,5 k € | +13.1% | 112,7 k € |
| Operating result | 44,5 k € | +21.1% | 36,7 k € | -35.6% | 57 k € | -54.8% | 126,3 k € | +13.5% | 111,2 k € |
| Net result | 6,4 k € | -78.1% | 29,4 k € | -14.6% | 34,4 k € | -64.5% | 97,1 k € | +30.5% | 74,4 k € |
| Balance sheet | |||||||||
| Equity | 388,7 k € | -1.6% | 395,1 k € | -3.8% | 410,7 k € | +1.1% | 406,2 k € | +19.4% | 340,2 k € |
| Total assets | 415,6 k € | -10.6% | 465 k € | -1.5% | 471,9 k € | +1.7% | 464,1 k € | +30.6% | 355,3 k € |
| Cash | 118,4 k € | +7.4% | 110,2 k € | -31.3% | 160,5 k € | -14.3% | 187,3 k € | +57.2% | 119,1 k € |
| Debts | 26,3 k € | -62.1% | 69,4 k € | +14.4% | 60,6 k € | +15.1% | 52,7 k € | +276% | 14 k € |
Board of directors
Source · NBB, accounts to 31/12/20221 active · 3 ended
Active mandates
Christina Staar
ActiveEnded mandates
Christina Staar
EndedChristina Staar
EndedJOOSTEN-STAAR DR. MED. CHRISTINA
EndedFinancials
Full financial information
Source · NBB| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 | 01/01/2018 | 01/01/2017 |
| Closing of the financial year | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 | 31/12/2018 | 31/12/2017 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 02/06/2023 | 07/03/2022 | 13/07/2021 | 17/07/2020 | 12/07/2019 | 11/07/2018 |
| General meeting | 24/05/2023 | 03/03/2022 | 16/06/2021 | 08/07/2020 | 12/06/2019 | 13/06/2018 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 11 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2022 | 24/05/2023 | 02/06/2023 | German | |
| Micro model | 31/12/2021 | 03/03/2022 | 07/03/2022 | German | |
| Micro model | 31/12/2020 | 16/06/2021 | 13/07/2021 | German | |
| Micro model | 31/12/2019 | 08/07/2020 | 17/07/2020 | German | |
| Micro model | 31/12/2018 | 12/06/2019 | 12/07/2019 | German | |
| Micro model | 31/12/2017 | 13/06/2018 | 11/07/2018 | German | |
| Micro model | 31/12/2016 | 14/06/2017 | 12/07/2017 | German | |
| Abridged model | 31/12/2015 | 25/05/2016 | 29/09/2016 | French | |
| Abridged model | 31/12/2014 | 27/05/2015 | 30/09/2015 | German | |
| Abridged model | 31/12/2013 | 04/06/2014 | 01/07/2014 | French | |
| Abridged model | 31/12/2012 | 26/06/2013 | 04/07/2013 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20221 active · 3 ended
Active mandates
Christina Staar
ActiveEnded mandates
Christina Staar
EndedChristina Staar
EndedJOOSTEN-STAAR DR. MED. CHRISTINA
EndedOwnership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Dissolution05/01/2024RUBRIK ENDE (EINSTELLUNG, WIDERRUF EINSTELLUNG, NICHTIGKEIT, USW...)
- Mandates31/12/2021AENDERUNG RECHTSFORM - GESELLSCHAFTSSITZ - ENTLASSUNG - ERNENNUNG
- Capital / shares30/07/2018KAPITAL - AKTIEN
- Capital / shares21/01/2014KAPITAL - AKTIEN - SATZUNGEN (UEBERSETZUNG, KOORDINATION, ANDERE AENDERUNGEN, )
- Other15/05/2012RUBRIK GRUENDUNG (NEUE RECHTSPERSON, EROEFFNUNG FILIALE, USW)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2022Annual accounts 20226,4 k €↓
- 2021Annual accounts 202129,4 k €↓
- 2020Annual accounts 202034,4 k €↓
- 2019Annual accounts 201997,1 k €↑
- 2018Annual accounts 201874,4 k €↑
- 2017Annual accounts 201754,8 k €↑
- 2016Annual accounts 201648 k €↓
- 2015Annual accounts 201560,5 k €↓
- 2014Annual accounts 201482,1 k €↑
- 2013Annual accounts 201335,9 k €